|By PR Newswire||
|April 3, 2014 07:47 PM EDT||
GREENWICH, Conn., April 3, 2014 /PRNewswire/ -- FrontFour Capital Group LLC, together with its affiliates ("FrontFour"), today commented on the resignation of Dr. Elaine R. Wedral, a director of Sensient Technologies Corporation (the "Company" or "Sensient"), from the board of directors of Balchem Corporation ("Balchem"), effectively acknowledging the inherent conflict that would have existed by her continued service on both boards following Balchem's announcement to acquire Performance Chemicals & Ingredients Company (d/b/a SensoryEffects), a direct competitor of Sensient, on March 31, 2014. FrontFour acknowledges that it inadvertently missed Balchem's disclosure made late on Friday, March 28, 2014, that Wedral notified Balchem of her intention to resign from the Balchem board, effective April 1, 2014.
FrontFour also addressed today its frustration with Sensient's continued attempt to obfuscate the depth of the Company's operational underperformance within their Flavors & Fragrances business when compared to that of relevant competitors. As illustrated by the charts below, Sensient continues to compare its Flavors and Fragrances margins to solely the Flavors margins of their competitors. The analysis below clearly demonstrates that Sensient underperforms its three direct competitors by approximately 160 to 360 basis points when viewed on an apples-to-apples basis. Additionally, Sensient excludes from segment income and lumps into their corporate/other line item, their Asia Pacific Group, China Group and Central & South American Flavors Group. We question why Sensient would lump these operating segments, representing approximately $150 million or 10% of 2013 revenue, within their corporate/other line item without adequate financial disclosure.
FrontFour has nominated four (4) nominees for election to the Sensient Board at the 2014 Annual Meeting of Shareholders. FrontFour encourages all shareholders to vote the GREEN proxy card today to elect FrontFour's highly qualified director nominees.
Shareholders who have any questions, or require assistance with their vote, should contact FrontFour's proxy solicitor, Okapi Partners LLC, at (212) 297-0720 or (877) 566-1922, or by email at [email protected].
FrontFour Capital Group LLC
35 Mason Street, 4th Floor
Greenwich, CT 06830
Bruce H. Goldfarb/Charles W. Garske/Lisa Patel
Okapi Partners LLC
SOURCE FrontFour Capital Group LLC
Jul. 28, 2016 12:49 PM EDT Reads: 237
Jul. 28, 2016 12:45 PM EDT Reads: 1,778
Jul. 28, 2016 12:30 PM EDT Reads: 573
Jul. 28, 2016 12:00 PM EDT Reads: 1,223
Jul. 28, 2016 11:15 AM EDT Reads: 1,136
Jul. 28, 2016 11:00 AM EDT Reads: 1,134
Jul. 28, 2016 11:00 AM EDT Reads: 1,789
Jul. 28, 2016 11:00 AM EDT Reads: 2,047
Jul. 28, 2016 10:45 AM EDT Reads: 1,273
Jul. 28, 2016 10:45 AM EDT Reads: 578
Jul. 28, 2016 10:41 AM EDT Reads: 308
Jul. 28, 2016 10:30 AM EDT Reads: 814
Jul. 28, 2016 10:15 AM EDT Reads: 516
Jul. 28, 2016 10:00 AM EDT Reads: 277
Jul. 28, 2016 09:30 AM EDT Reads: 1,406